0000874015-24-000133.txt : 20240313 0000874015-24-000133.hdr.sgml : 20240313 20240313175216 ACCESSION NUMBER: 0000874015-24-000133 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240226 FILED AS OF DATE: 20240313 DATE AS OF CHANGE: 20240313 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Jenne Kyle CENTRAL INDEX KEY: 0001791857 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19125 FILM NUMBER: 24747219 MAIL ADDRESS: STREET 1: C/O AKCEA THERAPEUTICS, INC. STREET 2: 22 BOSTON WHARF ROAD, 9TH FLOOR CITY: BOSTON STATE: MA ZIP: 02210 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IONIS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000874015 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 330336973 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 BUSINESS PHONE: 7609319200 MAIL ADDRESS: STREET 1: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 FORMER COMPANY: FORMER CONFORMED NAME: ISIS PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930328 4 1 edgardoc.xml PRIMARY DOCUMENT X0508 4 2024-02-26 0 0000874015 IONIS PHARMACEUTICALS INC IONS 0001791857 Jenne Kyle 2855 GAZELLE COURT CARLSBAD CA 92010 0 1 0 0 EVP, Chf GL Pdt Str Ofcr 0 Non-Qualified Stock Option (right to buy) 46.1 2024-02-26 4 A 0 65203 0.0 A 2025-02-26 2034-02-25 Common Stock 65203 65203 D Grant on 02/26/2024 to reporting person of stock options under the Ionis Pharmaceuticals, Inc. 2020 Equity Incentive Plan. Following this transaction, the option was exercisable as to 0 shares on 02/26/2024. 25% of the shares subject to the option will vest and become exercisable on 02/26/2025. Thereafter, the remaining shares subject to the option will vest and become exercisable in 36 equal monthly installments over the next 3 years. By: Patrick R. O'Neil, attorney-in-fact For: Kyle Jenne 2024-03-12